Mobilization of CD34+ cells in elderly patients (≥ 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen
暂无分享,去创建一个
B. Barlogie | E. Anaissie | G. Tricot | M. Zangari | E. Siegel | P. Lin | M. Cottler-Fox | C. Morris | A. Fassas
[1] Jennifer Fuller. Hematopoietic stem cells and aging. , 2002, Science of aging knowledge environment : SAGE KE.
[2] G. Perea,et al. Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma , 2001, Annals of Hematology.
[3] B. Barlogie,et al. Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years , 2001, British journal of haematology.
[4] B. Barlogie. High-dose therapy and innovative approaches to treatment of multiple myeloma. , 2001, Seminars in hematology.
[5] B. Barlogie,et al. Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony‐stimulating factor alone , 2001, British journal of haematology.
[6] J. S. San Miguel,et al. Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease. , 2001, Haematologica.
[7] D. Jolly,et al. Collection de cellules souches périphériques, recherche de facteurs prédictifs : une étude multicentrique , 2000 .
[8] C. Klersy,et al. Blood stem cell collections in multiple myeloma: definition of a scoring system , 2000, Bone Marrow Transplantation.
[9] F. Hernández-Navarro,et al. Factors influencing collection and engraftment of CD34+ cells in patients with breast cancer following high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation. , 2000, Journal of hematotherapy & stem cell research.
[10] C. Franceschi,et al. Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[11] M. Boccadoro,et al. Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients. , 1999, Blood.
[12] Jichun Chen,et al. Development and aging of primitive hematopoietic stem cells in BALB/cBy mice. , 1999, Experimental hematology.
[13] B. Barlogie,et al. Age is not a prognostic variable with autotransplants for multiple myeloma. , 1999, Blood.
[14] G. Salles,et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies , 1998, British journal of haematology.
[15] P. Cony-Makhoul,et al. Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study , 1998, Leukemia.
[16] G. Gleim,et al. CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] H. Goldschmidt,et al. Factors influencing collection of peripheral blood progenitor cells following high‐dose cyclophosphamide and granulocyte colony‐stimulating factor in patients with multiple myeloma , 1997, British journal of haematology.
[18] B. Barlogie,et al. Peripheral stem cell mobilization and engraftment in patients over age 60 , 1997, Bone Marrow Transplantation.
[19] B. Barlogie,et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. , 1997, Blood.
[20] J. Rossi,et al. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma , 1996 .
[21] R. Storb,et al. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. , 1996, Bone marrow transplantation.
[22] J. Rossi,et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. , 1996, The New England journal of medicine.
[23] R. Storb,et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] R. Storb,et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF): an analysis of factors correlating with the tempo of engraftment after transplantation , 1994, British journal of haematology.
[25] C. Franceschi,et al. Increased cytokine production in mononuclear cells of healthy elderly people , 1993, European journal of immunology.
[26] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .